nonprofit logo

International Myeloma Society

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 264220253 ✦ Boston, MA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is International Myeloma Society?

The International Myeloma Society (IMS) is a distinguished, professional, scientific, and medical organization based in Boston, Massachusetts. Its primary mission is to unite clinical and experimental scientists engaged in the study of myeloma. By fostering research, education, clinical trials, workshops, conferences, and symposiums on various aspects of multiple myeloma and related disorders globally, IMS aims to enhance our understanding of the disease's biology and therapy. The society's flagship event, the International Myeloma Workshop, is a significant biennial meeting focused on both basic, preclinical, and clinical aspects, including scientific programs, oral presentations, consensus panels, poster presentations, and stimulated debates. The 19th workshop involved over 1,300 participants, contributing to advancements in the field.


Official website here: www.myelomasociety.org/

What are the reviews and ratings of this charity?

Charity Navigator Rating: 80% (Three-Star out of Four Stars)

The International Myeloma Society has earned a solid Three-Star rating from Charity Navigator, indicating a commendable level of accountability and financial health. The charity's overall score reflects a strong focus on accountability, with all aspects of financial management evaluated positively. This suggests that donors can trust the organization to manage resources efficiently and transparently.

One of the key strengths of the International Myeloma Society is its strong governance structure, featuring a fully independent board of directors, which enhances the integrity of its operations. The organization has also demonstrated effective financial practices, as evidenced by a high program expense ratio of 98.35%, meaning that a significant portion of its funds directly supports its mission-related activities. Additionally, the society maintains a robust working capital ratio, ensuring financial stability.

However, while the rating is positive, it is worth noting that the evaluation is based solely on accountability and finance, with no additional beacons considered. This means that other important aspects such as impact measures or program effectiveness are not reflected in the overall rating. Potential donors may want to seek further insights about the outcomes and effectiveness of the society's programs to make a more informed decision.


This AI summary has been generated from information found on Charity Navigator.

Is International Myeloma Society legitimate?

International Myeloma Society is a legitimate nonprofit organization registered as a 501(c)(3) entity. International Myeloma Society submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $76,800

For more financial information, click here


Official website here: www.myelomasociety.org/

What is the mission statement of International Myeloma Society?

The International Myeloma Society, a professional, scientific, and medical organization, serves to unite clinical and experimental scientists engaged in the study of myeloma. Its primary purpose is to foster research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on various aspects of multiple myeloma and related disorders worldwide. By doing so, the society aims to advance knowledge and improve care for individuals affected by these conditions.


Official website here: www.myelomasociety.org/

Who is the CEO of International Myeloma Society?

Philippe Moureau is the President of International Myeloma Society.


Official website here: www.myelomasociety.org/

What is the revenue of International Myeloma Society?

International Myeloma Society's revenue in 2022 was $3,584,528.


Official website here: www.myelomasociety.org/

Who are the executives of International Myeloma Society and what are their salaries?

The average compensation at International Myeloma Society during 2022 was $76,800. There is 1 employee and 17 volunteers at International Myeloma Society.


Here are 14 key members and their salaries:


Nikhil C Munshi (President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Shajl Kumar (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marla-Victoria Mateos Paseo (Secretary)
  • Compensation: $0
  • Related: $0
  • Other: $0
Philippe Moreau (Vice President)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dorotea Fantl (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Francesca Gay (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Pjoy Ho (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Amrita Krishnan (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sundar Jagannath (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Pankaj Malhotra (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sonja Zweegman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kenneth C Anderson (Honorary Board)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert A Kyle (Honorary Board)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jesus San Miguel (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.myelomasociety.org/

Where can I find the form 990 for International Myeloma Society?

International Myeloma Society's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.myelomasociety.org/

Learn more at the official website: www.myelomasociety.org/

Mission Statement of International Myeloma Society

The International Myeloma Society, a distinguished professional, scientific, and medical organization, is committed to fostering collaboration among clinical and experimental scientists engaged in the study of myeloma. The primary objective of this society is to advance research, education, clinical trials (covering diagnosis and treatment), workshops, conferences, and symposia on various aspects of multiple myeloma and related disorders on a global scale. The International Myeloma Society serves as a hub for knowledge exchange, facilitating the sharing of insights and innovations in the field of myeloma research and treatment. By promoting such activities, the organization aims to contribute significantly to the understanding and management of myeloma, ultimately improving patient outcomes worldwide.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The International Myeloma Society (IMS) plays a crucial role in uniting clinical and experimental scientists dedicated to advancing the field of myeloma research and treatment. By fostering collaboration among experts, the society enhances the understanding of multiple myeloma and related disorders through robust scientific discourse.

Key to its impact is the International Myeloma Workshop, which serves as a landmark biennial meeting that brings together over 1,300 participants. This forum facilitates discussions on both basic biology and clinical advancements, featuring scientific programs, oral presentations, consensus panels, and poster presentations. The workshop not only stimulates debate but also furthers the collective knowledge of disease biology and therapeutic approaches.

By promoting research, education, and clinical studies, the IMS contributes significantly to the global medical community's efforts in diagnosing and treating multiple myeloma. Engaging in workshops, conferences, and symposia, the society ensures that advancements in myeloma research are disseminated widely, ultimately improving outcomes for patients affected by this complex disease.




This information is meant to be a general summary of International Myeloma Society. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$3,584,528 (2022)
Expenses
$2,623,443 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $88
  • Gross Receipts: $3,584,528

Assets and Liabilities:

  • Total Assets: $8,333,584
  • Total Liabilities: $6,646
  • Net Assets: $8,326,938

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2008

Principal Officer

Philippe Moureau

Main Address

75 STATE STREET 100, BOSTON, MA, 02109

NTEE Category

Code: H30 - Medical research

If you are a representative of International Myeloma Society and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.